Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...

We recently compiled a list of the 30 Most Important AI Stocks According to BlackRock. In this article, we are going to take ...

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...

As chronic illnesses rise and technology leaps forward, the demand for cutting-edge medical devices intensifies. Medtronic ...

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G, which earned clearance in the U.S. in April 2023. One of this device's biggest perks is that it features an ...

That includes the MiniMed 780G automated insulin delivery (AID) system, cleared by the U.S. Food and Drug Administration (FDA) in 2023. This helped the Diabetes segment's organic sales increase by ...

The headline numbers from Medtronic highlight a solid start to its fiscal 2025. For the company's first quarter, adjusted ...

The firm faced an FDA warning letter for Its MiniMed 600 insulin pump, which I highlighted in an earlier article. This, combined with competition from pod-based insulin delivery with no pumps or ...

U.S. revenues grew in the mid-teens on the continued adoption of the MiniMed 780G automated insulin delivery system. International revenues grew by low double digits on increasing CGM attachment ...